CERVARIX
As listed in the register: CERVARIX
20 mcg + 20 mcg · suspension
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Recombinant Human Papillomavirus Type 16 L1 Protein + Recombinant Human Papillomavirus Type 18 L1 Protein
- Made by
- Glaxosmithkline Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Glaxosmithkline Inc |
|---|---|
| Active substance | Recombinant Human Papillomavirus Type 16 L1 Protein + Recombinant Human Papillomavirus Type 18 L1 Protein |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Strength | 20 mcg + 20 mcg |
| Form | suspension |
| Classification | J07BM02 · Antibiotics, antivirals and antifungals taken into the body |
| Route | intramuscular |
| Dispensing (as stated by the register) | SCHEDULE D |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02342227 |
| DPD drug code | 82773 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.